Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the 1-year Relapse Rate in Patients with Pemphigus Treated According to the Revised Pemphigus PNDS (national Diagnosis and Care Protocol)

NCT06903494 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT06903494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06903494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the 1-year Relapse Rate in Patients with Pemphigus Treated According to the Revised Pemphigus PNDS (national Diagnosis and Care Protocol)
Lead sponsor
University Hospital, Rouen
Phase
Observational
Overall status
Completed
Start date
February 17, 2021
Completion date
March 1, 2025
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dermatology disease